Today's post from
painresearchforum.org (see link below) looks at the latest forms of
spinal cord stimulation to reduce chronic pain. Basically, this sort of
treatment involves implanting electrodes by the spinal cord. These are
then stimulated with electrical impulses and this results in less pain
signals being received by the brain. It's still a controversial
treatment in many circles because nobody is absolutely sure why it
works. This article looks at whether the process can be improved to
achieve better results.
Spinal Cord Stimulation: Promising Variation on a Theme?
Ramping up electrical frequency appears to alter neuronal activity in novel ways
by Stephani Sutherland on 14 Aug 2013
Spinal
cord stimulation (SCS)—the delivery of pulses of electric current
directly to the spinal cord via implanted electrodes—is an increasingly
utilized pain treatment that gives some relief to about half of people
with some types of neuropathic pain. Could it do better? This question
has recently prompted researchers and clinicians to consider variations
on the conventional SCS technique.
SCS typically involves
electrical pulses delivered at a frequency of 50 hertz (Hz). Now, a
study of SCS in animals suggests that high-frequency stimulation (at
1,000 or 10,000 Hz) can rapidly and effectively block pain
hypersensitivity in a rat model of neuropathic pain and does so through a
mechanism distinct from lower-frequency SCS. The findings provide
insight into the physiological effects of SCS and suggest that
alterations of the standard protocol may expand the potential use of SCS
as a pain treatment. The results, from Yun Guan at Johns Hopkins
University in Baltimore, Maryland, US, appeared in the August issue of
Anesthesiology.
While several groups have recently investigated the clinical benefits of high-frequency SCS, the results have been mixed (Van Buyten et al., 2012; Tiede et al., 2013; Perruchoud et al., 2013).
J. David Clark, an anesthesiologist at Stanford University in Palo
Alto, California, US, wrote in an editorial accompanying the new paper
that there has been “a conspicuous lack of … a clear physiological
rationale for this approach” of using high-frequency stimulation. The
new work addresses that need, he told PRF. Clark, who was not involved
in the work, said the findings could lead to a better understanding of
SCS that would allow practitioners to select among alternatives within
the basic realm of electrical stimulation, although more work will be
required to translate these findings in rodents to the clinic.
The
research team, including first author Ronen Shechter, used a spinal
nerve ligation model of neuropathic pain to investigate the analgesic
and electrophysiological effects of SCS in rats. In behavioral
experiments, the authors saw rats’ withdrawal threshold to mechanical
stimuli fall after nerve damage—indicating hypersensitivity—and then
recover with daily SCS treatment over three days. High-frequency (1 or
10 kHz) stimulation increased withdrawal threshold further and faster
than conventional 50 Hz stimulation did, working on the first day of
stimulation. The ultra-high frequency 10 kHz provided no added benefit
beyond 1 kHz.
Next, the team tested the possibility that SCS at
various frequencies might fundamentally alter the nerve fibers’
conduction properties. The researchers recorded from the peripheral
sciatic nerve while evoking action potentials at the spinal cord in rats
before and after high-frequency stimulation of the dorsal column,
similar to therapeutic SCS. They found that mechanically sensitive
Aα/β-fiber neurons were less active, particularly after high-frequency
stimulation, suggesting these neurons had indeed toned down their
excitability.
In another experiment, the researchers elicited
wind-up in wide dynamic range (WDR) neurons in the dorsal horn, an
experimental protocol thought to emulate spinal neuron hyperactivity in
neuropathic pain. After conventional 50 Hz SCS, but not high-frequency 1
kHz SCS, pain-sensing C-fibers contributed less to WDR neuron activity,
suggesting that less pain signal was getting through the spinal cord
relay station en route to the brain. These findings indicated that
several independent mechanisms may contribute to SCS-induced analgesia.
Just
how SCS works to diminish pain remains enigmatic, but hypotheses to
date have invoked the gate control theory, first described by Melzack and Wall in 1965.
Still, “it’s not clear cut how that might work,” said Guan of the
established framework. The theory holds that the experience of pain
arises from the net total of sensory input from various modalities that
goes through the “gate” of second-order spinal cord neurons. If
nociceptive C-fibers dominate the input, the result is pain; if input
from mechanically sensitive A-fibers can be amplified, pain is reduced.
One of Guan’s experiments supports this theory: Conventional SCS
decreased C-fiber input to WDR neurons. The other finding, that
A-fibers’ conduction was affected by high-frequency stimulation,
suggests another road to analgesia. And yet another distinct mechanism
probably contributes to SCS analgesia: activation of higher brain areas
that control descending pain modulation (Linderoth and Meyerson, 2010).
The
variable response to conventional SCS among patients with pain may stem
from the fact that different types of pain arise from different nerve
activities. About one fifth of people with neuropathic pain experience
mechanical hypersensitivity, or allodynia—a painful sensation to a
normally non-noxious touch—which is modeled in the rodent nerve injury
used in the current study. Allodynia is thought to arise from A-fiber
activity and so might be better treated with the high-frequency SCS that
slowed A-fiber conduction. On the other hand, the results suggest that
different types of pain involving overactive input from C-fibers might
respond better to conventional SCS.
Guan added that their
findings “indicate that the two frequencies may have different uses or
applications. When patients don’t respond to one frequency, maybe they
should try another.”
Although much work remains to understand
and optimize SCS, Guan said, the work adds flexibility to the technique.
Treating neuropathic pain is “like fighting a battle,” he said, and
better weapons are always welcome.
Stephani Sutherland, PhD, is a neuroscientist, yogi, and freelance writer in Southern California.
http://www.painresearchforum.org/news/30637-spinal-cord-stimulation-promising-variation-theme
No comments:
Post a Comment
All comments welcome but advertising your own service or product will unfortunately result in your comment not being published.